Expression of glutathione S-transferase variants in human airway wall after long-term response to sulfur mustard

Journal of Receptors and Signal Transduction

Volumn 34, Issue 2, 2014, Pages 125-130

  Nourani, Mohammad Reza ^a   Azimzadeh, Sadegh ^a   Ghanei, Mostafa ^a   Imani Fooladi, Abbas Ali ^b  

^a Chemical Injuries Research Center   (Iran)

^b BAQIYATALLAH UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Airway; Glutathione S transferase; Sulfur mustard

Indexed keywords

GLUTATHIONE TRANSFERASE; GLUTATHIONE TRANSFERASE A1; GLUTATHIONE TRANSFERASE M1; GLUTATHIONE TRANSFERASE P1; MESSENGER RNA; MUSTARD GAS; REACTIVE OXYGEN METABOLITE;

ADULT; AIRWAY DYNAMICS; ARTICLE; BRONCHOSCOPY; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; DETOXIFICATION; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; IRAN; LONG TERM EXPOSURE; LUNG ALVEOLUS WALL; MALE; OXIDATIVE STRESS; POLYMERASE CHAIN REACTION; PROTEIN FOLDING;

ADULT; CASE-CONTROL STUDIES; CHEMICAL WARFARE AGENTS; FEMALE; GLUTATHIONE S-TRANSFERASE PI; GLUTATHIONE TRANSFERASE; HUMANS; IMMUNOENZYME TECHNIQUES; MALE; MIDDLE AGED; MUSTARD GAS; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; REAL-TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER;

EID: 84897886513     PISSN: 10799893     EISSN: 15324281     Source Type: Journal    
DOI: 10.3109/10799893.2013.864677     Document Type: Article

References (46)

1. Zhang J, Wu L, Qu JM, et al. Pro-inflammatory phenotype of COPD fibroblasts not compatible with repair in COPD lung. J Cell Mol Med 2012;16:1522-32.
2. van den Berge M, Vonk JM, Gosman M, et al. Clinical and inflammatory determinants of bronchial hyperresponsiveness in COPD. Eur Respir J 2012;40:1098-105.
3. Valvi D, Mannino DM, Mullerova H, Tal-Singer R. Fibrinogen, chronic obstructive pulmonary disease (COPD) and outcomes in two United States cohorts. Int J Chron Obstruct Pulmon Dis 2012;7: 173-82.
4. Celli BR, MacNee W. Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paper. Eur Respir J 2004;23:932-46.
5. Pauwels RA, Rabe KF. Burden and clinical features of chronic obstructive pulmonary disease (COPD). Lancet 2004;364:613-20.
6. de Boer WI, Alagappan VK, Sharma HS. Molecular mechanisms in chronic obstructive pulmonary disease: potential targets for therapy. Cell Biochem Biophys 2007;47:131-48.
7. Sadowska AM, Manuel YKB, De Backer WA. Antioxidant and anti-inflammatory efficacy of NAC in the treatment of COPD: discordant in vitro and in vivo dose-effects: a review. Pulm Pharmacol Ther 2007;20:9-22.
8. Sadowska AM, Manuel-y-Keenoy B, De Backer WA. Inhibition of in vitro neutrophil migration through a bilayer of endothelial and epithelial cells using beta2-agonists: concomitant effects on IL-8 and elastase secretion and impact of glucocorticosteroids. Pulm Pharmacol Ther 2005;18:354-62.
9. Han S, Espinoza LA, Liao H, et al. Protection by antioxidants against toxicity and apoptosis induced by the sulphur mustard analog 2-chloroethylethyl sulphide (CEES) in Jurkat T cells and normal human lymphocytes. Br J Pharmacol 2004;141:795-802.
10. Korkmaz A, Yaren H, Topal T, Oter S. Molecular targets against mustard toxicity: implication of cell surface receptors, peroxynitrite production, and PARP activation. Arch Toxicol 2006;80:662-70.
11. Naghii MR. Sulfur mustard intoxication, oxidative stress, and antioxidants. Mil Med 2002;167:573-5.
12. Montuschi P, Collins JV, Ciabattoni G, et al. Exhaled 8-isoprostane as an in vivo biomarker of lung oxidative stress in patients with COPD and healthy smokers. Am J Respir Crit Care Med 2000;162: 1175-7.
13. Golpon HA, Coldren CD, Zamora MR, et al. Emphysema lung tissue gene expression profiling. Am J Respir Cell Mol Biol 2004; 31:595-600.
14. Yoneda K, Chang MM, Chmiel K, et al. Application of highdensity DNA microarray to study smoke- and hydrogen peroxideinduced injury and repair in human bronchial epithelial cells. J Am Soc Nephrol 2003;14:S284-9.
15. Cantin AM, North SL, Hubbard RC, Crystal RG. Normal alveolar epithelial lining fluid contains high levels of glutathione. J Appl Physiol 1987;63:152-7.
16. Rahman I, MacNee W. Lung glutathione and oxidative stress: implications in cigarette smoke-induced airway disease. Am J Physiol 1999;277:L1067-88.
17. Hayes JD, Pulford DJ. The glutathione S-transferase supergene family: regulation of GST and the contribution of the isoenzymes to cancer chemoprotection and drug resistance. Crit Rev Biochem Mol Biol 1995;30:445-600.
18. Sharma A, Patrick B, Li J, et al. Glutathione S-transferases as antioxidant enzymes: small cell lung cancer (H69) cells transfected with hGSTA1 resist doxorubicin-induced apoptosis. Arch Biochem Biophys 2006;452:165-73.
19. Autrup H. Genetic polymorphisms in human xenobiotica metabolizing enzymes as susceptibility factors in toxic response. Mutat Res 2000;464:65-76.
20. Harrison DJ, Cantlay AM, Rae F, et al. Frequency of glutathione Stransferase M1 deletion in smokers with emphysema and lung cancer. Hum Exp Toxicol 1997;16:356-60.
21. Ishii T, Matsuse T, Teramoto S, et al. Glutathione S-transferase P1 (GSTP1) polymorphism in patients with chronic obstructive pulmonary disease. Thorax 1999;54:693-696.
22. Yim JJ, Park GY, Lee CT, et al. Genetic susceptibility to chronic obstructive pulmonary disease in Koreans: combined analysis of polymorphic genotypes for microsomal epoxide hydrolase and glutathione S-transferase M1 and T1. Thorax 2000;55:121-5.
23. Yim JJ, Yoo CG, Lee CT, et al. Lack of association between glutathione S-transferase P1 polymorphism and COPD in Koreans. Lung 2002;180:119-25.
24. He JQ, Connett JE, Anthonisen NR, et al. Glutathione S-transferase variants and their interaction with smoking on lung function. Am J Respir Crit Care Med 2004;170:388-94.
25. Aynacioglu AS, Nacak M, Filiz A, et al. Protective role of glutathione S-transferase P1 (GSTP1) Val105Val genotype in patients with bronchial asthma. Br J Clin Pharmacol 2004;57:213-17.
26. Beheshti J, Mark EJ, Akbaei HMH, et al. Mustard lung secrets: long term clinicopathological study following mustard gas exposure. Pathol Res Pract 2006;202:739-44.
27. Koyama H, Geddes DM. Genes, oxidative stress, and the risk of chronic obstructive pulmonary disease. Thorax 1998;53:S10-14.
28. MacNee W. Oxidants/antioxidants and COPD. Chest 2000;117: 303S-17S.
29. Peterhans E. Oxidants and antioxidants in viral diseases: disease mechanisms and metabolic regulation. J Nutr 1997;127:962S-5S.
30. Schwarz KB. Oxidative stress during viral infection: a review. Free Radic Biol Med 1996;21:641-9.
31. Greene LS. Asthma, oxidant stress, and diet. Nutrition 1999;15: 899-907.
32. Langen RC, Korn SH, Wouters EF. ROS in the local and systemic pathogenesis of COPD. Free Radic Biol Med 2003;35:226-35.
33. Husain K, Dube SN, Sugendran K, et al. Effect of topically applied sulphur mustard on antioxidant enzymes in blood cells and body tissues of rats. J Appl Toxicol 1996;16:245-8.
34. Ebrahimi M, Roudkenar MH, Imani Fooladi AA, et al. Discrepancy between mRNA and protein expression of neutrophil gelatinaseassociated lipocalin in bronchial epithelium induced by sulfur mustard. J Biomed Biotechnol 2010;2010:823131.
35. Baranova H, Perriot J, Albuisson E, et al. Peculiarities of the GSTM1 0/0 genotype in French heavy smokers with various types of chronic bronchitis. Hum Genet 1997;99:822-6.
36. Sandford AJ, Pare PD. Genetic risk factors for chronic obstructive pulmonary disease. Clin Chest Med 2000;21:633-43.
37. Kushman ME, Kabler SL, Ahmad S, et al. Cytotoxicity and mutagenicity of dibenzo[a,l]pyrene and (+/-)-dibenzo[a,l]pyrene- 11,12-dihydrodiol in V79MZ cells co-expressing either hCYP1A1 or hCYP1B1 together with human glutathione-S-transferase A1. Mutat Res 2007;624:80-7.
38. Anttila S, Hirvonen A, Vainio H, et al. Immunohistochemical localization of glutathione S-transferases in human lung. Cancer Res 1993;53:5643-8.
39. Gilliland FD, McConnell R, Peters J, Gong H Jr. A theoretical basis for investigating ambient air pollution and childrens respiratory health. Environ Health Perspect 1999;107:403-7.
40. Hayes JD, Strange RC. Potential contribution of the glutathione S-transferase supergene family to resistance to oxidative stress. Free Radic Res 1995;22:193-207.
41. Strange RC, Spiteri MA, Ramachandran S, Fryer AA. Glutathione- S-transferase family of enzymes. Mutat Res 2001;482:21-6.
42. Hayes JD, Strange RC. Glutathione S-transferase polymorphisms and their biological consequences. Pharmacology 2000;61: 154-66.
43. Khaheshi I, Keshavarz S, Imani Fooladi AA, et al. Loss of expression of TGF-bs and their receptors in chronic skin lesions induced by sulfur mustard as compared with chronic contact dermatitis patients. BMC Dermatol 2011;11:2.
44. Nourani MR, Owada Y, Kitanaka N, et al. Localization of epidermal-type fatty acid binding protein in macrophages in advanced atretic follicles of adult mice. J Mol Histol 2005;36: 391-400.
45. Nourani MR, Yazdani S, Habibi Roudkenar M, et al. HO1 mRNA and protein do not change in parallel in bronchial biopsies of patients after long term exposure to sulfur mustard. Gene Regul Syst Biol 2010;4:83-90.
46. Nourani MR, Ebrahimi M, Roudkenar MH, et al. Sulfur mustard induces expression of metallothionein-1A in human airway epithelial cells. Int J Gen Med 2011;4:413-19.